$89.57
-3.04-3.28%
Last update: Nov 10, 11:20 AM
LivaNova PLC (LIVN) Stock Price, Quote, News & History
LIVNNASDAQ
LivaNova gets Buy rating from Goldman Sachs analyst. $65 PT. The company appears poised for consistent revenue growth in its base business.
You can purchase shares of LivaNova (NASDAQ:LIVN) through any online brokerage.
Other companies in LivaNova’s space includes: Abbott Laboratories (NYSE:ABT), Intuitive Surgical Inc (NASDAQ:ISRG), Medtronic PLC (NYSE:MDT), Stryker Corp (NYSE:SYK) and Boston Scientific Corp (NYSE:BSX).
LivaNova has a consensus price target of $84.75.
The stock price for LivaNova (NASDAQ: LIVN) is $89.57 last updated November 10, 2026 at 11:20 AM EST.
There are no upcoming dividends for LivaNova.
LivaNova does not have any upcoming earnings scheduled.
There is no upcoming split for LivaNova.
LivaNova is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the NASDAQ.
UK-based LivaNova was born of a combination of Cyberonics in the US and Sorin in Italy. The medical-device firm is primarily focused on cardiopulmonary solutions (with heart-lung machines and oxygenation equipment) as well as neuromodulation devices...
